Sigma Planning’s OncoSec Medical ONCS Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCS
SM
LFCM
Sigma Planning's ONCS Position: Q4 2021 in Review
Sigma Planning sold out of OncoSec Medical (ONCS) in Q4 2021, closing a stake of 614 shares — an estimated $29K sold.
Sigma Planning first reported a position in ONCS in Q1 2020 and held it in 7 quarters. The position peaked at $212K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.
- Sigma Planning reported no remaining OncoSec Medical position as of Q4 2021 after selling out during the quarter.
- Sigma Planning sold 614 OncoSec Medical shares in Q4 2021, an estimated $29K.
- Sigma Planning first reported a position in OncoSec Medical in Q1 2020 and held it in 7 quarters.
- Sigma Planning's OncoSec Medical position peaked at $212K in Q4 2020.
- 34 funds tracked by Wall St. Rank held OncoSec Medical as of Q4 2021.
Based on Sigma Planning's 13F filing for Q4 2021, filed 2 Feb 2022.